Read here for an analysis of General Motors (GM) stock's discounted prospects amidst Cruise restructuring, tariff concerns, ...

Robert Half's stock has underperformed, losing 20% in the past year, and further downside is expected due to macro headwinds.

LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced the closing of its previously announced registered ...

Beijing launched a stimulus blitz in September to rescue the housing and stock markets in an effort ... The sector contributed about a quarter of China’s gross domestic product, before the ...

Property developer SM Prime Holdings, Inc. (SMPH) plans to invest up to P33 billion in 2025 to expand its commercial property ...

Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical-stage biopharmaceutical company focused on the development of innovative ...

The shares of common stock of the Company are expected to begin trading on the Nasdaq Capital Market on February 12, 2025, under the ticker symbol “AGH.” The Offering is expected to close on February ...

Morgan Stanley, BofA Securities, Cantor and RBC Capital Markets are acting as joint book running managers for the offering.

(Photo by Rachel Woolf/Special to The Denver Post) Cowboys and cowgirls fitted in their finest huddled around the star of the penultimate night of the National Western Stock Show clamoring for a ...

Most brokerages are upbeat on the stock’s prospects after the Q3FY25 ... bottomed out despite continued year-on-year pressure on gross refining margins of transportation fuels such as petrol ...